Jpmorgan Chase & CO 908 Devices Inc. Transaction History
Jpmorgan Chase & CO
- $1.27 Trillion
- Q1 2025
A detailed history of Jpmorgan Chase & CO transactions in 908 Devices Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 12,534 shares of MASS stock, worth $102,653. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,534
Previous 11,747
6.7%
Holding current value
$102,653
Previous $25,000
124.0%
% of portfolio
0.0%
Previous 0.0%
Shares
20 transactions
Others Institutions Holding MASS
# of Institutions
107Shares Held
24.4MCall Options Held
39KPut Options Held
11.9K-
Awm Investment Company, Inc. New York, NY5.2MShares$42.6 Million5.32% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.65MShares$21.7 Million0.16% of portfolio
-
State Street Corp Boston, MA2.29MShares$18.7 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.69MShares$13.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$11.7 Million0.0% of portfolio
About 908 Devices Inc.
- Ticker MASS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 31,590,200
- Market Cap $259M
- Description
- 908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-...